Top Stories
The FDA cleared the first autonomous AI cancer diagnosis system (Paige AI's PathAssist), allowing AI to make diagnostic decisions for certain pathology slides without physician confirmation. This sets a major regulatory precedent for autonomous AI in clinical settings.
Mayo Clinic completed its system-wide deployment of AI ambient documentation, reporting 40% reduction in physician documentation time and measurable decreases in clinician burnout across all departments.
Drug Discovery
Google DeepMind released AlphaFold 4 with breakthrough drug-protein interaction prediction. Eli Lilly, Novartis, and AstraZeneca have signed early access agreements. Novo Nordisk also announced an enterprise-wide partnership with OpenAI for drug discovery acceleration.
Regulatory Update
The EU AI Act classifies clinical decision support AI as high-risk, requiring mandatory human oversight and conformity assessments. Health systems deploying AI need to begin compliance planning now. FDA has cleared over 1,250 AI medical devices total, with 295 in 2025 alone.
What to Watch
- Ambient documentation is becoming table stakes — Abridge, DAX Copilot, and Freed are the three leading platforms
- Digital pathology AI is moving from screening to autonomous diagnosis — watch for more FDA clearances
- AI mental health chatbots show promising RCT results (Dartmouth's Therabot: 51% depression symptom reduction) but face clinician pushback